Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5981 USD | -8.13% | -20.25% | +75.81% |
09/05 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.81% | 1.14Cr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- EF Hutton Adjusts Price Target on Monopar Therapeutics to $17 From $24, Maintains Buy Rating